Skip to main content
Caplight Logo









Provigate, Inc.

Provigate, Inc.

Private
TokyoHealthcare & Life Scienceshttps://provigate.com/en/

Last Round

Grant

Oct 28, 2024

Total Funding Raised

$13.33M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Provigate, Inc. is a healthcare technology company that develops non-invasive blood glucose monitoring sensors, devices, and digital health applications to support diabetes prevention and management.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Patient Engagement

Business Model

B2B

Customer Profile

Services & Consulting, Hardware + Subscription

AI Layer

Application

Keywords

glucose monitoringglycated albuminGAdiabetes managementcgmdigital healthremote patient monitoringRPMbiosensorhealth techbehavioral change appminimally invasivepre-diabeteshealth and productivity managementmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Provigate, Inc. Comparables

Compare Provigate, Inc. with similar companies based on industry and business-model similarity.

Provigate, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Epinex Diagnostics, Inc.
77%
Orange Biomed
66%
Roche Holding
64%

Provigate, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 28, 2024
Series BOct 28, 2024
VC RoundJan 18, 2022
StrategicJan 18, 2022
VC RoundSep 27, 2021
Grant
Jul 29, 2021

Key People

Founding team and executive leadership

Koshin Sekimizu

President and CEO

Executive Team

Provigate, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 290% MoM to 5.6K.

  • Sep 17, 2025

    Exhibiting at Global Startup EXPO 2025 in Osaka, September 17-18.

Provigate, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Provigate, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Provigate, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range14
Year Founded2015
Last FundingOct 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?